Abstract

Disproportionate, maladapted, and generalized fear are essential hallmarks of posttraumatic stress disorder (PTSD), which develops upon severe trauma in a subset of exposed individuals. Among the brain areas that are processing fear memories, the hippocampal formation exerts a central role linking emotional-affective with cognitive aspects. In the hippocampus, neuronal excitability is constrained by multiple GABAergic interneurons with highly specialized functions and an extensive repertoire of co-released neuromodulators. Neuropeptide Y (NPY) is one of these co-transmitters that significantly affects hippocampal signaling, with ample evidence supporting its fundamental role in emotional, cognitive, and metabolic circuitries. Here we investigated the role of NPY in relation to GABA, both released from the same interneurons of the dorsal dentate gyrus (DG), in different aspects of fear conditioning. We demonstrated that activation of dentate GABA neurons specifically during fear recall reduced cue-related as well as trace-related freezing behavior, whereas inhibition of the same neurons had no significant effects. Interestingly, concomitant overexpression of NPY in these neurons did not further modify fear recall, neither under baseline conditions nor upon chemogenetic stimulation. However, potentially increased co-release of NPY substantially reduced contextual fear, promoted extinction learning, and long-term suppression of fear in a foreground context–conditioning paradigm. Importantly, NPY in the dorsal DG was not only expressed in somatostatin neurons, but also in parvalbumin-positive basket cells and axoaxonic cells, indicating intense feedback and feedforward modulation of hippocampal signaling and precise curtailing of neuronal engrams. Thus, these findings suggest that co-release of NPY from specific interneuron populations of the dorsal DG modifies dedicated aspects of hippocampal processing by sharpening the activation of neural engrams and the consecutive fear response. Since inappropriate and generalized fear is the major impediment in the treatment of PTSD patients, the dentate NPY system may be a suitable access point to ameliorate PTSD symptoms and improve the inherent disease course.

Highlights

  • Neuropeptide Y (NPY) is a 36 amino acid peptide neurotransmitter (Tatemoto et al, 1982) and extensively expressed in the peripheral and central nervous systems (Gehlert et al, 1987; Morris, 1989)

  • Two weeks after recombinant adeno-associated viral (rAAV) injection, hippocampus-dependent fear processing was tested by trace fear conditioning, a paradigm that relies on dorsal hippocampal signaling (Misane et al, 2005; Esclassan et al, 2009)

  • Trace fear conditioning was optimized in pilot studies for C57Bl6N/Crl mice

Read more

Summary

Introduction

Neuropeptide Y (NPY) is a 36 amino acid peptide neurotransmitter (Tatemoto et al, 1982) and extensively expressed in the peripheral and central nervous systems (Gehlert et al, 1987; Morris, 1989). The hippocampal formation, for instance, is processing and integrating particular contextual contents about place and time into other fear-relevant brain circuitries (Maren and Fanselow, 1995; Cox et al, 2013; Hubner et al, 2014; McDonald and Mott, 2017). These phenomena can be investigated by cued, contextual and trace fear conditioning

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call